These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. [Oncogens. Their origin, distribution, structure and functions in carcinogenesis]. Seits IF; Kniazev PG; Fedorov SN Vopr Onkol; 1982; 28(10):95-114. PubMed ID: 6755899 [No Abstract] [Full Text] [Related]
44. [Detection of cellular sensitization in mice after treatment with chemical carcinogens]. Gryschek G; Schlott B; Fey F; Albrecht S; Pasternak G Arch Geschwulstforsch; 1983; 53(1):29-36. PubMed ID: 6407456 [TBL] [Abstract][Full Text] [Related]
45. Unique patterns of gene expression changes in liver after treatment of mice for 2 weeks with different known carcinogens and non-carcinogens. Iida M; Anna CH; Holliday WM; Collins JB; Cunningham ML; Sills RC; Devereux TR Carcinogenesis; 2005 Mar; 26(3):689-99. PubMed ID: 15618236 [TBL] [Abstract][Full Text] [Related]
46. Modus operandi of carcinogens: mere temporal advancement. Kothari ML; Mehta LA J Postgrad Med; 1969 Jul; 15(3):101-5. PubMed ID: 5381283 [No Abstract] [Full Text] [Related]
47. Nutritional factors and etiologic mechanisms in the causation of gastrointestinal cancers. Weisburger JH; Wynder EL; Horn CL Cancer; 1982 Dec; 50(11 Suppl):2541-9. PubMed ID: 7139548 [No Abstract] [Full Text] [Related]
48. Nine-week detection of six genotoxic lung carcinogens using the rasH2/BHT mouse model. Umemura T; Kodama Y; Nishikawa A; Hioki K; Nomura T; Kanki K; Kuroiwa Y; Ishii Y; Kurokawa Y; Hirose M Cancer Lett; 2006 Jan; 231(2):314-8. PubMed ID: 16399233 [TBL] [Abstract][Full Text] [Related]
49. [Syncancerogenesis]. Schmähl D Dtsch Med Wochenschr; 1966 Oct; 91(40):1799-800. PubMed ID: 5332131 [No Abstract] [Full Text] [Related]
51. [Cellular mechanism of chemical carcinogenesis]. Vasil'ev IuM; Gel'shteĭn VI Tsitologiia; 1965; 7(3):302-11. PubMed ID: 5326153 [No Abstract] [Full Text] [Related]
52. Localized interfacial forces resulting from implanted plastics as possible physical factors involved in tumor formation. Kordan HA J Theor Biol; 1967 Oct; 17(1):1-11. PubMed ID: 6055371 [No Abstract] [Full Text] [Related]
53. Proposed research and regulatory plan to improve risk evaluation concerning factors contributing to the incidence of cancer and genetic damage. Kolbye AC Regul Toxicol Pharmacol; 1982 Sep; 2(3):232-7. PubMed ID: 7186172 [No Abstract] [Full Text] [Related]
54. The carcinogenic action of hormones. DAVIS JW South Med Surg; 1947 Mar; 109(3):63-5. PubMed ID: 20287414 [No Abstract] [Full Text] [Related]
55. Some aspects of cancer hormone relationships. NOBLE RL Can Med Assoc J; 1955 Oct; 73(8):654-62. PubMed ID: 13261012 [No Abstract] [Full Text] [Related]
56. [Hormones and malignant tumors]. Safier M Rass Clin Ter; 1966; 65(5):266-81. PubMed ID: 5340920 [No Abstract] [Full Text] [Related]
59. In vivo experiments with carcinogens. X. SAMPEY JR Am J Pharm Sci Support Public Health; 1956 Sep; 128(9):305-16. PubMed ID: 13372758 [No Abstract] [Full Text] [Related]
60. In vivo experiments with carcinogens. VI. SAMPEY JR J S C Med Assoc; 1955 Sep; 51(9):316-8. PubMed ID: 13252651 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]